Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
unimore.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
☰
Pubblicazioni
BREAST CANCER RESEARCH AND TREATMENT
Rivista
Codice:
E024890
ISSN:
0167-6806
Dati Generali
Dati Generali
Pubblicazioni (36)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients
Articolo
A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer
Articolo
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial
Articolo
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.
Articolo
Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome
Articolo
Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: results from a multicenter study in Italy
Articolo
Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: Results from a multicenter study in Italy
Articolo
Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
Articolo
Biomarker expression and survival after primary chemotherapy for breast cancer.
Abstract
Breast reduction and cancer in the gland remnant: a review
Articolo
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study.
Articolo
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: Results from a collaborative multicenter study in Italy
Articolo
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat
Articolo
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation
Articolo
Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial
Articolo
Epirubicin plus low dose trastuzumab in HER2 positive metastatic breast cancer
Articolo
Epirubicin/vinorelbine as first line therapy in metastatic breast cancer.
Articolo
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y)
Articolo
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study
Articolo
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology
Articolo
Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience
Articolo
IMPROVED SURVIVAL AFTER RADIOTHERAPY FOR BRAIN METASTASES IN PATIENTS WITH HER2 POSITIVE BREAST TUMORS
Abstract
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal
Articolo
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.
Articolo
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability
Abstract
Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
Articolo
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
Articolo
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
Articolo
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation
Abstract
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
Articolo
Pneumonitis and pulmonary fibrosis associated with breast cancer treatments
Articolo
Polimorfismo dell'apolipoproteina E nel carcinoma mammario: correlazione con i parametri clinico-patologici e prognosi.
Libro
Prognostic value of pathologic complete response after primary chemotherapy in patients with hormone receptor-positive breast cancer.
Abstract
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
Articolo
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.
Articolo
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
